SCHEMBL5807332

SCHEMBL5807332

O=C1Cc2cc3c(cc2N1Cc1ccccc1)N(Cc1ccccc1)C(=O)C3

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.59
MEN1 O00255 6/20 0.59
MAPT P10636 5/20 0.59
ALDH1A1 P00352 3/20 0.59
APAF1 O14727 2/20 0.59
HPGD P15428 1/20 0.59
POLB P06746 2/20 0.57
BLM P54132 2/20 0.51
USP2 O75604 2/20 0.51
KDM4E B2RXH2 1/20 0.51
RECQL P46063 1/20 0.51
MAPK1 P28482 1/20 0.51
CASP6 P55212 1/20 0.50
F2 P00734 1/20 0.50
PLG P00747 1/20 0.50
ELANE P08246 1/20 0.50
CTSG P08311 1/20 0.50
CMA1 P23946 1/20 0.50
CTRC Q99895 1/20 0.50
GSK3A P49840 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597487 0.84 POLB (0.73) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL578257 0.84 POLB (0.73) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL578321 0.83 POLB (0.54) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL27377771 0.83 POLB (0.54) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL578266 0.83 KMT2A (0.62) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL578360 0.79 MEN1 (0.57) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL30068092 0.79 MEN1 (0.57) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL18006543 0.78 MAPT (0.48) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL11616274 0.78 CASP1 (0.60) KMT2AMEN1MAPTALDH1A1APAF1
SCHEMBL18006542 0.78 POLB (0.49) KMT2AMEN1MAPTALDH1A1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006107644-A1 COLORANT COMPOUNDS, INTERMEDIATES, AND COMPOSITIONS MILLIKEN & COMPANY (US) 2006-10-12 WO disclosed
US-20060223993-A1 Colorant compounds, intermediates, and compositions MILLIKEN & COMPANY 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223993-A1 Colorant compounds, intermediates, and compositions AAAS, TST, AADAC KMT2A 2510/4885MEN1 2096/4885MAPT 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.